Ares Capital Earnings Calls
| Release date | Oct 28, 2025 |
| EPS estimate | $0.500 |
| EPS actual | $0.500 |
| Revenue estimate | 795.196M |
| Revenue actual | 655M |
| Revenue Surprise | -17.63% |
| Release date | Jul 29, 2025 |
| EPS estimate | $0.506 |
| EPS actual | $0.500 |
| EPS Surprise | -1.19% |
| Revenue estimate | 748.826M |
| Revenue actual | 822M |
| Revenue Surprise | 9.77% |
| Release date | Apr 29, 2025 |
| EPS estimate | $0.530 |
| EPS actual | $0.500 |
| EPS Surprise | -5.66% |
| Revenue estimate | 763.625M |
| Revenue actual | 599M |
| Revenue Surprise | -21.56% |
| Release date | Feb 05, 2025 |
| EPS estimate | $0.580 |
| EPS actual | $0.550 |
| EPS Surprise | -5.17% |
| Revenue estimate | 785.396M |
| Revenue actual | 393M |
| Revenue Surprise | -49.96% |
Last 4 Quarters for Ares Capital
Below you can see how ARCC performed 4 days prior and 4 days after releasing the earnings report. Also, you can see the pre-estimates and the actual earnings. This information can give you a slight idea of what you might expect for the next quarter's release.
| Release date | Feb 05, 2025 |
| Price on release | $23.10 |
| EPS estimate | $0.580 |
| EPS actual | $0.550 |
| EPS surprise | -5.17% |
| Date | Price |
|---|---|
| Jan 30, 2025 | $23.42 |
| Jan 31, 2025 | $23.67 |
| Feb 03, 2025 | $23.80 |
| Feb 04, 2025 | $23.81 |
| Feb 05, 2025 | $23.10 |
| Feb 06, 2025 | $22.73 |
| Feb 07, 2025 | $22.74 |
| Feb 10, 2025 | $22.87 |
| Feb 11, 2025 | $22.71 |
| 4 days before | -1.37% |
| 4 days after | -1.69% |
| On release day | -1.60% |
| Change in period | -3.03% |
| Release date | Apr 29, 2025 |
| Price on release | $20.67 |
| EPS estimate | $0.530 |
| EPS actual | $0.500 |
| EPS surprise | -5.66% |
| Date | Price |
|---|---|
| Apr 23, 2025 | $20.75 |
| Apr 24, 2025 | $21.10 |
| Apr 25, 2025 | $21.11 |
| Apr 28, 2025 | $21.25 |
| Apr 29, 2025 | $20.67 |
| Apr 30, 2025 | $20.66 |
| May 01, 2025 | $20.34 |
| May 02, 2025 | $20.80 |
| May 05, 2025 | $20.53 |
| 4 days before | -0.386% |
| 4 days after | -0.677% |
| On release day | -0.0484% |
| Change in period | -1.06% |
| Release date | Jul 29, 2025 |
| Price on release | $22.54 |
| EPS estimate | $0.506 |
| EPS actual | $0.500 |
| EPS surprise | -1.19% |
| Date | Price |
|---|---|
| Jul 23, 2025 | $23.07 |
| Jul 24, 2025 | $23.03 |
| Jul 25, 2025 | $23.11 |
| Jul 28, 2025 | $22.70 |
| Jul 29, 2025 | $22.54 |
| Jul 30, 2025 | $22.63 |
| Jul 31, 2025 | $22.63 |
| Aug 01, 2025 | $22.39 |
| Aug 04, 2025 | $22.40 |
| 4 days before | -2.30% |
| 4 days after | -0.621% |
| On release day | 0.399% |
| Change in period | -2.90% |
| Release date | Oct 28, 2025 |
| Price on release | $20.57 |
| EPS estimate | $0.500 |
| EPS actual | $0.500 |
| Date | Price |
|---|---|
| Oct 22, 2025 | $19.96 |
| Oct 23, 2025 | $19.94 |
| Oct 24, 2025 | $20.08 |
| Oct 27, 2025 | $20.32 |
| Oct 28, 2025 | $20.57 |
| Oct 29, 2025 | $20.61 |
| Oct 30, 2025 | $20.15 |
| Oct 31, 2025 | $20.35 |
| Nov 03, 2025 | $20.41 |
| 4 days before | 3.06% |
| 4 days after | -0.778% |
| On release day | 0.194% |
| Change in period | 2.25% |
Ares Capital Earnings Call Transcript Summary of Q3 2025
Ares Capital reported solid Q3 2025 results: core EPS of $0.50 (stable QoQ) and GAAP EPS of $0.57, driven by strong net realized gains (Q3 net realized gains reported ~$247M) including a sizable realized gain on Potomac. NAV rose for the ninth time in 10 quarters. Origination and deployment activity accelerated — $3.9B of new commitments in Q3, $1.3B net deployment, and a $28.7B portfolio at fair value. Credit metrics remain healthy: organic LTM EBITDA growth for portfolio companies is in the low double digits, interest coverage is >2x, weighted average LTVs in the low-40% range, and nonaccruals declined (1.8% at cost; 1.0% at fair value). Funding and liquidity are strong (liquidity ~$6.2B; debt/equity net of cash ~1.02x), with recent debt refinancings and a $650M unsecured note issuance swapped to floating rate. Management reiterated confidence in sustaining the $0.48 quarterly dividend (payable Dec 30) — citing multiple levers (unused leverage capacity around 1x, opportunity in the 30% nonqualifying asset basket, potential fee income from increased activity, and ~$1.26 per share of taxable income “spillover” as a cushion). Market backdrop: transaction activity and M&A are firming, bid-ask spreads are narrowing, and ARCC notes increased pipeline/backlog (backlog ~$3B as of Oct 23). Management emphasized selective underwriting, sector specialization (notably defensive software exposure), and Ares’s scale/origination advantage as drivers of continued credit performance.
Sign In
Buy ARCC